The US FDA's Good Manufacturing Practices Inspection of Piramal Pharma Limited's Digwal facility was completed successfully, the company said through an exchange filing. The inspection that was held from March 27 to March 31 was completed successfully with Zero Form -483 observations.
The company in an exchange filing said, "The company is committed to maintaining the highest standards of compliance."
Piramal Pharma shares
The shares of Piramal Pharma on Friday closed at Rs 68.75, up by 2.54 per cent.
AUS vs IND 1st Test: What Is Snake Crack? Will It Rattle Team India At Perth In The Border Gavaskar Series Opener?
CHSE Odisha Releases Class 12 Board Exam Timetable; Exams Commence form 18 February
7 Contributions By CV Raman That Changed The Way We See Physics Today
Who Is Sagar Adani? Executive Director Of Adani Green Energy At The Center Of ₹2,110 Crore US Bribery Allegations
